These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20039891)
1. Failure of rituximab treatment in a case of severe thyroid ophthalmopathy unresponsive to steroids. Krassas GE; Stafilidou A; Boboridis KG Clin Endocrinol (Oxf); 2010 Jun; 72(6):853-5. PubMed ID: 20039891 [No Abstract] [Full Text] [Related]
2. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712 [TBL] [Abstract][Full Text] [Related]
3. [Biological treatment options for Graves' ophthalmopathy]. El Fassi D; Nielsen CH; Hegedüs L Ugeskr Laeger; 2008 Jun; 170(24):2128-30. PubMed ID: 18565294 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723 [TBL] [Abstract][Full Text] [Related]
5. Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy. Nielsen JF; El Fassi D; Nielsen CH; Hegedüs L; Lauer SA; Silkiss RZ; Prause JU Acta Ophthalmol; 2009 Nov; 87(8):927-9. PubMed ID: 19785644 [No Abstract] [Full Text] [Related]